Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prediction of Etiology and Prognosis Based on Hematoma Location of Spontaneous Intracerebral Hemorrhage

NCT06498778 is registered in ClinicalTrials.gov with Jinling Hospital, China as lead sponsor.

NCT NCT06498778
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06498778 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prediction of Etiology and Prognosis Based on Hematoma Location of Spontaneous Intracerebral Hemorrhage
Lead sponsor
Jinling Hospital, China
Phase
Observational
Overall status
Completed
Start date
July 1, 2021
Completion date
May 31, 2023
Enrollment
698 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spontaneous intracerebral hemorrhage